What marijuana reclassification means for the United States

The US Associated Press report that "The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less dangerous drug. The Justice Department proposal would recognize the medical uses of cannabis, but wouldn’t legalize it for recreational use. The proposal would move marijuana from the “Schedule I” group to the less tightly regulated “Schedule III.” So what does that mean, and what are the implications? ... Because marijuana is on Schedule I, it’s been very difficult to conduct authorized clinical studies that involve administering the drug. That has created something of a Catch-22: calls for more research, but barriers to doing it. (Scientists sometimes rely instead on people’s own reports of their marijuana use.) Schedule III drugs are easier to study, though the reclassification wouldn’t immediately reverse all barriers to study."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Next
Next

Mind the psychedelic hype: Characterizing the risks and benefits of psychedelics for depression